newsfilter
← Latest News
Business Wire·

Humanigen Signs Contract With Clinigen for Lenzilumab Managed Access Program in Europe

Program designed to fulfill requests from healthcare providers for access to lenzilumab, for patients with unmet medical needs Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating